Patents by Inventor Lin Yan

Lin Yan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220233647
    Abstract: Glucose-responsive insulin conjugates that contain one or more linear oligomer sugar cluster are provided. Such insulin conjugates that may display a pharmacokinetic (PK) and/or pharmacodynamic (PD) profile that is responsive to the systemic concentrations of a saccharide such as glucose or alpha-methylmannose, even when administered to a subject in need thereof in the absence of an exogenous multivalent saccharide-binding molecule.
    Type: Application
    Filed: June 1, 2020
    Publication date: July 28, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Danqing Feng, Songnian Lin, Dmitri A. Pissarnitski, Brenda Pipik, Lin Yan, Yuping Zhu
  • Publication number: 20220217131
    Abstract: A networking method for a household appliance, a household appliance, and a terminal device are provided. The household appliance is provided with a network module. According to the method, the network module receives router information and the account and the password of a router transmitted by a mobile terminal. The router information contains time-related data required for logging into the router; according to the router information and the account and the password of the router, log into the router.
    Type: Application
    Filed: March 24, 2022
    Publication date: July 7, 2022
    Applicants: GD MIDEA AIR-CONDITIONING EQUIPMENT CO., LTD., MIDEA GROUP CO., LTD.
    Inventor: Lin YAN
  • Patent number: 11058775
    Abstract: Insulin dimers conjugated to peptides having at least one incretin activity are disclosed.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: July 13, 2021
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Anandan Palani, Zhiqiang Yang, Lin Yan, Songnian Lin, Pei Huo, Ravi Nargund
  • Publication number: 20210198339
    Abstract: The present disclosure provides conjugates that comprise an insulin molecule conjugated via a conjugate framework to two or more separate ligands that each include a saccharide, wherein the framework, ligand, saccharide and insulin molecule optionally comprise a fatty chain (e.g., a C8-30 fatty chain), wherein when said insulin molecule is conjugated both to a C8-30 fatty chain and one or more separate ligands that each include a saccharide, said C8-30 fatty chain is linked to insulin molecule only, and wherein when the framework or ligand comprises a fatty chain the insulin molecule is conjugated to two or more separate ligands. In certain embodiments, a conjugate is characterized in that, when the conjugate is administered to a mammal, at least one pharmacokinetic (PK) and/or pharmacodynamic (PD) property of the conjugate is sensitive to serum concentration of a second saccharide. In certain embodiments, a conjugate is also characterized by having a protracted PK profile.
    Type: Application
    Filed: December 13, 2018
    Publication date: July 1, 2021
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Lin Yan, Pei Huo, Ahmet Kekec, Danqing D. Feng, Yuping Zhu, Dmitri Pissarnitski, Chris Moyes, Songnian Lin
  • Patent number: 11041009
    Abstract: An insulin conjugate comprising or consisting of a tri-valent sugar cluster is described. In particular aspects, the insulin conjugate displays a pharmacokinetic (PK) and/or pharmacodynamic (PD) profile that is responsive to the systemic concentrations of a saccharide such as glucose or alpha-methylmannose even when administered to a subject in need thereof in the absence of an exogenous multivalent saccharide-binding molecule such as Con A.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: June 22, 2021
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Danqing Feng, Pei Huo, Ahmet Kekec, Songnian Lin, Christopher R. Moyes, Ravi Nargund, Brenda Pipik, Dmitri A. Pissarnitski, Lin Yan, Yuping Zhu
  • Publication number: 20210177981
    Abstract: The present disclosure provides conjugates which comprise an insulin molecule conjugated via a conjugate framework to one or more separate ligands that include a first saccharide, and wherein the conjugate framework also comprises a fatty chain (e.g., a C8-30 fatty chain). In certain embodiments, a conjugate is characterized in that, when the conjugate is administered to a mammal, at least one pharmacokinetic (PK) and/or pharmacodynamic (PD) property of the conjugate is sensitive to serum concentration of a second saccharide. In certain embodiments, a conjugate is also characterized by having a protracted PK profile. Exemplary conjugates and sustained release formulations are provided in addition to methods of use and preparation.
    Type: Application
    Filed: December 13, 2018
    Publication date: June 17, 2021
    Applicants: Merck Sharp & Dohme Corp., SmartCells, Inc.
    Inventors: Lin Yan, Pei Huo, Ahmet Kekec, Yuping Zhu, Dmitri Pissarnitski, Danqing D. Feng, Chris Moyes, Zhiqiang Zhao, David N. Hunter, Songnian Lin, Thomas M. Lancaster, Benjamin Chen
  • Publication number: 20210163568
    Abstract: The present invention relates to insulin analogues and processes of making such insulin analogues by direct conversion of a free amine to an azide via diazo-transfer with an azotransfer agent.
    Type: Application
    Filed: April 8, 2019
    Publication date: June 3, 2021
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Sobhana Babu Boga, Ahmet Kekec, Songnian Lin, Craig A. Parish, Weijuan Tang, Lin Yan
  • Publication number: 20210099871
    Abstract: A system for integrating wireless service providers' core networks with Wi-Fi radios using a Wireless Services Gateway (WSG). The WSG can allow wireless device users to seamlessly connect to a network such as the internet using both cellular phone antennae as well as Wi-Fi radio antennae while still utilizing their preferred wireless service provider's core network system of billing, authenticating and policy decision making. This system can allow for data transmission of wireless devices through Wi-Fi instead of through cellular antennae, thus increasing bandwidth and data transmission rates.
    Type: Application
    Filed: December 11, 2020
    Publication date: April 1, 2021
    Applicant: ARRIS Enterprises LLC
    Inventors: Hemant Bhatnagar, Wayne Chuu, Chetan Hebbalae, Wei-Lun Huang, Rajesh Kaliaperumal, William Kish, Yi-Nan Li, Ronald Mok, Vijikumar Nagaraja, Venkatarao Palli, Yogesh Ranade, Ming-Jye Sheu, Henry Tzeng, You-Lin Yan, Thomas Yu
  • Patent number: 10887767
    Abstract: A system for integrating wireless service providers' core networks with Wi-Fi radios using a Wireless Services Gateway (WSG). The WSG can allow wireless device users to seamlessly connect to a network such as the internet using both cellular phone antennae as well as Wi-Fi radio antennae while still utilizing their preferred wireless service provider's core network system of billing, authenticating and policy decision making. This system can allow for data transmission of wireless devices through Wi-Fi instead of through cellular antennae, thus increasing bandwidth and data transmission rates.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: January 5, 2021
    Assignee: ARRIS Enterprises LLC
    Inventors: Hemant Bhatnagar, Wayne Chuu, Chetan Hebbalae, Wei-Lun Huang, Rajesh Kaliaperumal, William Kish, Yi-Nan Li, Ronald Mok, Vijikumar Nagaraja, Vankatarao Palli, Yogesh Ranade, Ming-Jye Sheu, Henry Tzeng, You-Lin Yan, Thomas Yu
  • Patent number: 10800827
    Abstract: Insulin dimers and insulin analog dimers that act as partial agonists at the insulin receptor are disclosed.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: October 13, 2020
    Assignee: MERCK SHARP & DOHME CORP.
    Inventors: Songnian Lin, Lin Yan, Pei Huo, Dmitri Pissarnitski, Danqing Feng, Ravi Nargund, Yuping Zhu, Ahmet Kekec, Christina B. Madsen-Duggan, Zhi-Cai Shi, Zhicai Wu, Yingjun Mu
  • Patent number: 10689430
    Abstract: Insulin dimers and insulin analog dimers that act as partial agonists at the insulin receptor are disclosed.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: June 23, 2020
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Songnian Lin, Lin Yan, Pei Huo, Dmitri Pissarnitski, Danqing Feng, Ravi Nargund, Christina Madsen-Duggan, Yuping Zhu, Ahmet Kekec, Zhicai Wu
  • Publication number: 20200087375
    Abstract: An insulin conjugate comprising or consisting of a tri-valent sugar cluster is described. In particular aspects, the insulin conjugate displays a pharmacokinetic (PK) and/or pharmacodynamic (PD) profile that is responsive to the systemic concentrations of a saccharide such as glucose or alpha-methylmannose even when administered to a subject in need thereof in the absence of an exogenous multivalent saccharide-binding molecule such as Con A.
    Type: Application
    Filed: March 19, 2018
    Publication date: March 19, 2020
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Danqing Feng, David N. Hunter, Pei Huo, Ahmet Kekec, Songnian Lin, Christopher R. Moyes, Ravi Nargund, Brenda Pipik, Dmitri A. Pissarnitski, Lin Yan, Zhiqiang Zhao, Yuping Zhu
  • Publication number: 20190261445
    Abstract: A system for integrating wireless service providers' core networks with Wi-Fi radios using a Wireless Services Gateway (WSG). The WSG can allow wireless device users to seamlessly connect to a network such as the internet using both cellular phone antennae as well as Wi-Fi radio antennae while still utilizing their preferred wireless service provider's core network system of billing, authenticating and policy decision making. This system can allow for data transmission of wireless devices through Wi-Fi instead of through cellular antennae, thus increasing bandwidth and data transmission rates.
    Type: Application
    Filed: March 12, 2019
    Publication date: August 22, 2019
    Inventors: Hemant Bhatnagar, Wayne Chuu, Chetan Hebbalae, Wei-Lun Huang, Rajesh Kaliaperumal, William Kish, Yi-Nan Li, Ronald Mok, Vijikumar Nagaraja, Vankatarao Palli, Yogesh Ranade, Ming-Jye Sheu, Henry Tzeng, You-Lin Yan, Thomas Yu
  • Patent number: 10382588
    Abstract: Resource access driven distributed transaction coordination system is described. A method may include receiving a request to perform a migration of user data from a first user account to a second user account and restricting access to a distributed resource as a result of receiving the request. When a distributed process requests access to a distributed resource, and that distributed process doesn't have any pending tasks, account migration may be performed.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: August 13, 2019
    Assignee: Electronic Arts Inc.
    Inventors: Lin Yan, Zhaoquan Zheng, Shengyong Li, Chuan Ye, Daniel Windrem, Ryan Thomas Butterfoss
  • Publication number: 20190192675
    Abstract: Insulin dimers conjugated to peptides having at least one incretin activity are disclosed.
    Type: Application
    Filed: April 21, 2017
    Publication date: June 27, 2019
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Anandan PALANI, ZhiQiang YANG, Lin YAN, Songnian LIN, Pei HUO, Ravi NARGUND
  • Publication number: 20190175744
    Abstract: Insulin-incretin conjugates comprising a peptide having agonist activity at the glucagon-like 1 (GLP-1) receptor, the glucagon (GCG) receptor, and/or the gastric inhibitory protein (GIP) receptor conjugated to an insulin molecule having agonist activity at the insulin receptor and use of the conjugates for treatment of metabolic diseases, for example, Type 2 diabetes, are described.
    Type: Application
    Filed: March 13, 2017
    Publication date: June 13, 2019
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Anandan Palani, Chunhui Huang, Zhiqiang Yang, Lin Yan, Songnian Lin, Pei Huo, Qiaolin Deng, Elisabetta Bianchi, Federica Orvieto
  • Publication number: 20190177393
    Abstract: Insulin dimers and insulin analog dimers that act as partial agonists at the insulin receptor are disclosed.
    Type: Application
    Filed: May 23, 2017
    Publication date: June 13, 2019
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Songnian Lin, Lin Yan, Pei Huo, Dmitri Pissarnitski, Danqing Feng, Ravi Nargund, Christina Madsen-Duggan, Yuping Zhu, Ahmet Kekec, Zhicai Wu
  • Patent number: 10278226
    Abstract: A system for integrating wireless service providers' core networks with Wi-Fi radios using a Wireless Services Gateway (WSG). The WSG can allow wireless device users to seamlessly connect to a network such as the internet using both cellular phone antennae as well as Wi-Fi radio antennae while still utilizing their preferred wireless service provider's core network system of billing, authenticating and policy decision making. This system can allow for data transmission of wireless devices through Wi-Fi instead of through cellular antennae, thus increasing bandwidth and data transmission rates.
    Type: Grant
    Filed: May 13, 2017
    Date of Patent: April 30, 2019
    Assignee: ARRIS Enterprises LLC
    Inventors: Hemant Bhatnagar, Wayne Chuu, Chetan Hebbalae, Wei-Lun Huang, Rajesh Kaliaperumal, William Kish, Yi-Nan Li, Ronald Mok, Vijikumar Nagaraja, Venkatarao Palli, Yogesh Ranade, Ming-Jye Sheu, Henry Tzeng, You-Lin Yan, Thomas Yu
  • Publication number: 20190092833
    Abstract: Insulin dimers and insulin analog dimers that act as partial agonists at the insulin receptor are disclosed.
    Type: Application
    Filed: November 26, 2018
    Publication date: March 28, 2019
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Songnian Lin, Lin Yan, Pei Huo, Dmitri Pissarnitski, Danqing Feng, Ravi Nargund, Yuping Zhu, Ahmet Kekec, Christina B. Madsen-Duggan, Zhi-Cai Shi, Zhicai Wu, Yingjun Mu
  • Patent number: 10242308
    Abstract: The present invention provides a radio frequency identification and sensing device comprising an antenna module, a RFID sensing module, and battery module. The antenna module has a first flexible substrate having an antenna circuit formed thereon. The RFID sensing module comprises a second flexible substrate, a RFID chip, a sensor formed on the second flexible substrate and a memory module formed on the second flexible substrate, wherein the sensor is utilized to detecting an environmental status for generating a plurality of sensing data, and the memory module is utilized to store the plurality of sensing data. The RFID chip is utilized to transfer the plurality of data to a reading device. The battery module is utilized to provide electrical power for operating the RFID sensing module.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: March 26, 2019
    Assignee: Securitag Assembly Group Co., Ltd
    Inventors: Tian lin Yan, Cheng hung Chang, Way Yu Chen